{"id":"tp-54642","type":"article-newspaper","title":"Kura Oncology Receives $55 Million Under Oberland Capital Agreement","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54642","datePublished":"2026-11-11T23:44:14.000Z","dateModified":"2026-11-11T23:44:14.000Z","language":"en","abstract":"The agreement provides up to $300 million in potential funding, subject to conditions. Kura plans a roughly 40-patient darlifarnib study in the first half of 2027.","section":"Business","references":[]}